An American Enterprise Institute study found that Medicaid is wasting hundreds of millions of dollars each year purchasing name-brand drugs instead of lower-cost generics. "Rising pharmaceutical costs, the aging population and increased use of costly specialty drugs makes containing drug-related spending an urgent health system priority closely linked to expanding access to care and improving quality," said National Coalition on Health Care President and CEO Ralph Neas.

Full Story:
Hill, The

Related Summaries